New Report Affirms Safety and Efficacy of Early Measles Vaccination for Infants Amid U.S. Resurgence
Rapid Read

New Report Affirms Safety and Efficacy of Early Measles Vaccination for Infants Amid U.S. Resurgence

What's Happening? A new report from the Center for Infectious Disease Research and Policy’s (CIDRAP) Vaccine Integrity Project (VIP) at the University of Minnesota highlights that infants as young as 6 months can safely receive the measles, mumps, and rubella (MMR) vaccine. This comes as the U.S. fa
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.